Logo image of BRYN.DE

BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Stock Fundamental Analysis

FRA:BRYN - Deutsche Boerse Ag - US0846707026 - Common Stock - Currency: EUR

409  -3.2 (-0.78%)

Fundamental Rating

4

BRYN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 47 industry peers in the Financial Services industry. Both the profitability and the financial health of BRYN get a neutral evaluation. Nothing too spectacular is happening here. BRYN may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BRYN had positive earnings in the past year.
BRYN had a positive operating cash flow in the past year.
BRYN had positive earnings in 4 of the past 5 years.
In the past 5 years BRYN always reported a positive cash flow from operatings.
BRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFBRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B 60B 80B

1.2 Ratios

The Return On Assets of BRYN (6.95%) is better than 79.17% of its industry peers.
BRYN has a Return On Equity (12.36%) which is comparable to the rest of the industry.
BRYN's Return On Invested Capital of 4.50% is in line compared to the rest of the industry. BRYN outperforms 54.17% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BRYN is significantly below the industry average of 10.14%.
The 3 year average ROIC (4.13%) for BRYN is below the current ROIC(4.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.95%
ROE 12.36%
ROIC 4.5%
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
BRYN.DE Yearly ROA, ROE, ROICBRYN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

BRYN's Profit Margin of 21.79% is fine compared to the rest of the industry. BRYN outperforms 75.00% of its industry peers.
In the last couple of years the Profit Margin of BRYN has declined.
BRYN has a Operating Margin (15.89%) which is comparable to the rest of the industry.
BRYN's Operating Margin has improved in the last couple of years.
BRYN's Gross Margin of 16.43% is on the low side compared to the rest of the industry. BRYN is outperformed by 62.50% of its industry peers.
BRYN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.89%
PM (TTM) 21.79%
GM 16.43%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
BRYN.DE Yearly Profit, Operating, Gross MarginsBRYN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

BRYN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for BRYN has been reduced compared to 1 year ago.
BRYN has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, BRYN has an improved debt to assets ratio.
BRYN.DE Yearly Shares OutstandingBRYN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
BRYN.DE Yearly Total Debt VS Total AssetsBRYN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B 1T

2.2 Solvency

Based on the Altman-Z score of 1.34, we must say that BRYN is in the distress zone and has some risk of bankruptcy.
BRYN's Altman-Z score of 1.34 is in line compared to the rest of the industry. BRYN outperforms 41.67% of its industry peers.
BRYN has a debt to FCF ratio of 10.44. This is a negative value and a sign of low solvency as BRYN would need 10.44 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 10.44, BRYN is in line with its industry, outperforming 47.92% of the companies in the same industry.
BRYN has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
BRYN's Debt to Equity ratio of 0.19 is fine compared to the rest of the industry. BRYN outperforms 70.83% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 10.44
Altman-Z 1.34
ROIC/WACC1.4
WACC3.22%
BRYN.DE Yearly LT Debt VS Equity VS FCFBRYN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

2.3 Liquidity

A Current Ratio of 1.14 indicates that BRYN should not have too much problems paying its short term obligations.
BRYN has a Current ratio (1.14) which is in line with its industry peers.
BRYN has a Quick Ratio of 1.14. This is a bad value and indicates that BRYN is not financially healthy enough and could expect problems in meeting its short term obligations.
BRYN has a Quick ratio of 0.91. This is in the lower half of the industry: BRYN underperforms 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.91
BRYN.DE Yearly Current Assets VS Current LiabilitesBRYN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B

4

3. Growth

3.1 Past

BRYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.77%, which is quite good.
The Earnings Per Share has been growing by 17.78% on average over the past years. This is quite good.
BRYN shows a small growth in Revenue. In the last year, the Revenue has grown by 0.63%.
BRYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.84% yearly.
EPS 1Y (TTM)13.77%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%-14.02%
Revenue 1Y (TTM)0.63%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%-0.16%

3.2 Future

The Earnings Per Share is expected to grow by 2.26% on average over the next years.
The Revenue is expected to grow by 4.89% on average over the next years.
EPS Next Y-6.33%
EPS Next 2Y-0.17%
EPS Next 3Y1.54%
EPS Next 5Y2.26%
Revenue Next Year-2.46%
Revenue Next 2Y1.29%
Revenue Next 3Y-0.36%
Revenue Next 5Y4.89%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BRYN.DE Yearly Revenue VS EstimatesBRYN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100B 200B 300B 400B
BRYN.DE Yearly EPS VS EstimatesBRYN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10K 20K 30K

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 0.02, the valuation of BRYN can be described as very cheap.
BRYN's Price/Earnings ratio is rather cheap when compared to the industry. BRYN is cheaper than 100.00% of the companies in the same industry.
BRYN is valuated cheaply when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
BRYN is valuated cheaply with a Price/Forward Earnings ratio of 0.01.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BRYN indicates a rather cheap valuation: BRYN is cheaper than 100.00% of the companies listed in the same industry.
BRYN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.90.
Industry RankSector Rank
PE 0.02
Fwd PE 0.01
BRYN.DE Price Earnings VS Forward Price EarningsBRYN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

BRYN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BRYN is cheaper than 100.00% of the companies in the same industry.
100.00% of the companies in the same industry are more expensive than BRYN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.06
EV/EBITDA 1.15
BRYN.DE Per share dataBRYN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100K 200K 300K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0
EPS Next 2Y-0.17%
EPS Next 3Y1.54%

0

5. Dividend

5.1 Amount

No dividends for BRYN!.
Industry RankSector Rank
Dividend Yield N/A

BERKSHIRE HATHAWAY INC-CL B

FRA:BRYN (7/4/2025, 7:00:00 PM)

409

-3.2 (-0.78%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)05-03 2025-05-03/bmo
Earnings (Next)08-01 2025-08-01
Inst Owners33.78%
Inst Owner ChangeN/A
Ins Owners38.2%
Ins Owner ChangeN/A
Market Cap588.96M
Analysts80
Price Target460.55 (12.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)16.51%
Min EPS beat(2)-9.78%
Max EPS beat(2)42.8%
EPS beat(4)2
Avg EPS beat(4)10.96%
Min EPS beat(4)-10.41%
Max EPS beat(4)42.8%
EPS beat(8)6
Avg EPS beat(8)11.15%
EPS beat(12)8
Avg EPS beat(12)9.18%
EPS beat(16)11
Avg EPS beat(16)8.21%
Revenue beat(2)0
Avg Revenue beat(2)-2.05%
Min Revenue beat(2)-4.09%
Max Revenue beat(2)-0.01%
Revenue beat(4)0
Avg Revenue beat(4)-2.99%
Min Revenue beat(4)-7.69%
Max Revenue beat(4)-0.01%
Revenue beat(8)4
Avg Revenue beat(8)0.2%
Revenue beat(12)5
Avg Revenue beat(12)-0.61%
Revenue beat(16)6
Avg Revenue beat(16)-0.89%
PT rev (1m)-3.52%
PT rev (3m)-5.41%
EPS NQ rev (1m)0.42%
EPS NQ rev (3m)-2.27%
EPS NY rev (1m)-0.67%
EPS NY rev (3m)-3.44%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)-0.98%
Revenue NY rev (1m)-4.03%
Revenue NY rev (3m)-2.47%
Valuation
Industry RankSector Rank
PE 0.02
Fwd PE 0.01
P/S 0
P/FCF 0.06
P/OCF 0.02
P/B 0
P/tB 0
EV/EBITDA 1.15
EPS(TTM)27110.27
EY6628.43%
EPS(NY)27946.63
Fwd EY6832.92%
FCF(TTM)7120.31
FCFY1740.91%
OCF(TTM)18253.1
OCFY4462.86%
SpS219120.92
BVpS386244.37
TBVpS315751
PEG (NY)N/A
PEG (5Y)0
Profitability
Industry RankSector Rank
ROA 6.95%
ROE 12.36%
ROCE 5.56%
ROIC 4.5%
ROICexc 4.68%
ROICexgc 5.61%
OM 15.89%
PM (TTM) 21.79%
GM 16.43%
FCFM 3.25%
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
ROICexc(3y)4.31%
ROICexc(5y)3.94%
ROICexgc(3y)5.19%
ROICexgc(5y)4.78%
ROCE(3y)5.11%
ROCE(5y)4.61%
ROICexcg growth 3Y9.15%
ROICexcg growth 5Y4.04%
ROICexc growth 3Y9.9%
ROICexc growth 5Y4.98%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 10.44
Debt/EBITDA 1.75
Cap/Depr 145.65%
Cap/Sales 5.08%
Interest Coverage 11.99
Cash Conversion 42.99%
Profit Quality 14.91%
Current Ratio 1.14
Quick Ratio 0.91
Altman-Z 1.34
F-Score4
WACC3.22%
ROIC/WACC1.4
Cap/Depr(3y)148.32%
Cap/Depr(5y)138.32%
Cap/Sales(3y)5.18%
Cap/Sales(5y)5.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.77%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%-14.02%
EPS Next Y-6.33%
EPS Next 2Y-0.17%
EPS Next 3Y1.54%
EPS Next 5Y2.26%
Revenue 1Y (TTM)0.63%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%-0.16%
Revenue Next Year-2.46%
Revenue Next 2Y1.29%
Revenue Next 3Y-0.36%
Revenue Next 5Y4.89%
EBIT growth 1Y12.44%
EBIT growth 3Y18.52%
EBIT growth 5Y13.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-47.83%
FCF growth 3Y-23.7%
FCF growth 5Y-12.55%
OCF growth 1Y-21.13%
OCF growth 3Y-8.11%
OCF growth 5Y-4.59%